ZIVO Bioscience, Inc. ZIVOW
Dec 26, 2025, 9:58 AM EST
- YTD
- +43,900.00%
- 1 year
- +43,900.00%
- Market cap
- 164.23K
- Revenue (ttm)
- 59.32K
- YTD return
- +43900.00%
- 1-year return
- +43900.00%
- Volume
- 3.00K
- Avg volume
- 4.39K
- Open
- 0.044
- Previous close
- 0.044
- Day's range
- 0.044 – 0.044
- 52-week range
- 0.62 – 0.62
- Beta
- 0.26
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -18.14K
- Total cash
- 2.47K
- Total debt
- 578.45K
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Consensus EPS estimate 0.00.
About ZIVO Bioscience, Inc.
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- zivobioscience.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on ZIVOW — it syncs with the Stock Master app.